Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat

• Published in: Laboratory animals (London) Vol. 39; no. 3; pp. 314 - 320
• Main Authors: Garin, E, Denizot, B, Roux, J, Noiret, N, Lepareur, N, Moreau, M, Mesba, H, Laurent, J.F, Herry, J.Y, Bourguet, P
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.07.2005; Sage Publications Ltd
• Subjects: Anesthetics; animal models; Animals; carcinoma; Carcinoma, Hepatocellular - pathology; Carcinoma, Hepatocellular - radiotherapy; Cell Line, Tumor; Disease Models, Animal; Female; Injections, Intra-Arterial; Iodine Radioisotopes - therapeutic use; Iodized Oil - administration & dosage; Iodized Oil - therapeutic use; Isoflurane; Ketamine; laboratory animals; Radioisotopes - therapeutic use; radiotherapy; Rats; Rats, Sprague-Dawley; Rhenium - therapeutic use; Time Factors; RAT; HEPATOMA; LIPIODOL; INTRA-ARTERIAL INJECTION
• ISSN: 0023-6772; 1758-1117
• DOI: 10.1258/0023677054307051

Intra-arterial metabolic radiotherapy (using lipiodol labelled with iodine-131 or rhenium-188) is a therapeutic approach that can be used for the treatment of hepatocellular carcinomas (HCC). We propose a detailed description of the tumoral model using the N1-S1 cell line as well as a technique for intra-arterial injection of radiolabelled lipiodol in order to undertake preclinical studies necessary for the evaluation of a new molecule. We also report the principal technical pitfalls that were faced. The speed of injection of the tumoral cells is a key factor in the tumoral induction since slow injections lead to a tumoral induction rate of 36.3% compared with 76.6% (P < 0.01) when using very slow injections. This parameter should thus be controlled carefully during the subcapsular injection of the tumoral cells. In addition, when injecting radiolabelled lipiodol, anaesthesia should not be performed with isoflurane since this leads to a reduction in tumoral uptake. Indeed, we found a 'tumour/healthy liver' uptake ratio of only 2.1 +/- 0.7 with isoflurane as against 4.4 +/- 2.6 (P < 0.05) when anaesthesia was carried out by intraperitoneal injection of ketamine. Lastly, we show that the tumour size has an influence on the tumoral uptake of radiolabelled lipiodol; therefore, this parameter must also be carefully controlled.